WinstonWınston
America Great Health logo

America Great Health

AAGH
27
Biotechnology · Healthcare
Price
$0.00
+0.00 (+0.00%)
Market Cap
$2.1M
Winston Score
27
Winston is worried
Below-average fundamentals — multiple weak pillars.

Share count rising — dilution

+3.5% over 4y

The company has issued more shares over this period, which dilutes each existing shareholder’s stake.

Diluted shares outstanding: 20.44B (2021) → 21.14B (2025)

America Great Health is a small biotechnology company focused on health and wellness products. It sells supplements and related consumer health goods, targeting everyday customers looking for nutritional support. The company operates in the broader healthcare and wellness industry, which is highly competitive and crowded with both large and small players.

The company generates revenue primarily through product sales, likely through direct-to-consumer and online channels. It is a very small company, with a market cap that rounds to essentially zero, meaning it has minimal scale compared to industry peers. The company's operating margin is deeply negative, meaning it spends far more than it earns, which is a serious financial risk — the biggest challenge it faces is reaching a size where revenue can actually cover its costs and sustain the business long-term.

Winston Score History

Growth Profile

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

+9.3% YoY

YoY Growth Rate

Slow revenue growth

EPS Growth

+100.0% YoY

YoY Growth Rate

EPS growth accelerating

R&D Spend

$0/ year

0.0% of revenue

Below sector average (18%)

Research and development spending

Insider Activity

9.5%ownership

Flat

Insiders holding steady — not selling despite ability to

Cash Runway

~0 months

$44,056 cash & investments

Quarterly Free Cash Flow

→ Burn rate stable

Short runway — potential dilution ahead through share issuance

Cash watch

America Great Health has less than a year of cash at its current burn rate. Growth investors should watch for potential share dilution from future fundraising — that directly reduces your ownership.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Gross Margin
74.1%
Premium pricing power — 74.1% gross margin
Operating Margin
-101.6%
Losing money on operations — -101.6%
ROCE
N/A
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales YoY
+1.5%
Nearly flat sales (1.5% YoY)
EPS YoY
N/A
Data not available
EPS Consistency
0/8 quarters
Earnings rarely grow — volatile business

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Cash Conversion
N/A
Data not available
FCF Margin
-210.9%
Burning cash (-210.9%)

Free cash flow is negative. They are burning cash, not generating it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

Debt / Equity
N/A
Data not available
Interest Cover
N/A
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

P/E Ratio (TTM)
1.0x
Attractive valuation — P/E 1.0

P/E under 10. The price tag is small relative to last year's profit.

P/E vs Forward
N/A
not available
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial